Advancing Implant Technologies to Extend Durability, Reduce Patient Burden & Support Long-Term Treatment of Dry AMD
Time: 2:30 pm
day: Day1
Details:
- Exploring how implantable drug delivery systems are engineered to provide sustained, controlled release of therapeutics directly to retinal tissues
- Evaluating delivery platform considerations for small molecule and biologic therapies, and how disease stage and progression patterns influence implant design and treatment duration
- Reviewing ongoing trial investigating implant-based delivery approach; insights into trial design, patient recruitment challenges, and early safety signals
